Peter Wung is a Rheumatology/Immunology physician affiliated with AbbVie. OpenAlex indexes 28 publications with 448 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St Ste 450
Houston, TX 77030
Telephone
713-486-3100Provider last certified this registry record 20 May 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20221 payment
- Janssen Biotech, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
Arthritis Research & Therapy
2025 - POS1274 IMPROVEMENTS IN BILAG MUSCULOSKELETAL AND MUCOCUTANEOUS DOMAINS AT WEEK 48 IN A PHASE 2 DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ABBV-599 (ELSUBRUTINIB + UPADACITINIB COMBINATION) AND UPADACITINIB MONOTHERAPY FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS
Annals of the Rheumatic Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”